Faculty of Chemistry, Jagiellonian University, 30-387 Krakow, Poland.
Małopolska Center of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
Int J Mol Sci. 2020 Nov 18;21(22):8716. doi: 10.3390/ijms21228716.
Resistance of microorganisms to antibiotics has led to research on various therapeutic strategies with different mechanisms of action, including photodynamic inactivation (PDI). In this work, we evaluated a cationic, neutral, and anionic -tetraphenylporphyrin derivative's ability to inactivate the Gram-negative and Gram-positive bacteria in a planktonic suspension under blue light irradiation. The spectroscopic, physicochemical, redox properties, as well as reactive oxygen species (ROS) generation capacity by a set of photosensitizers varying in lipophilicity were investigated. The theoretical calculations were performed to explain the distribution of the molecular charges in the evaluated compounds. Moreover, logP partition coefficients, cellular uptake, and phototoxicity of the photosensitizers towards bacteria were determined. The role of a specific microbial efflux pump inhibitor, verapamil hydrochloride, in PDI was also studied. The results showed that exhibited higher resistance to PDI than (3-5 logs) with low light doses (1-10 J/cm). In turn, the prolongation of irradiation (up to 100 J/cm) remarkably improved the inactivation of pathogens (up to 7 logs) and revealed the importance of photosensitizer photostability. The PDI potentiation occurs after the addition of KI (more than 3 logs extra killing). Verapamil increased the uptake of photosensitizers (especially in ) due to efflux pump inhibition. This effect suggests that PDI is mediated by ROS, the electrostatic charge interaction, and the efflux of photosensitizers (PSs) regulated by multidrug-resistance (MDR) systems. Thus, MDR inhibition combined with PDI gives opportunities to treat more resistant bacteria.
微生物对抗生素的耐药性导致了各种具有不同作用机制的治疗策略的研究,包括光动力失活(PDI)。在这项工作中,我们评估了阳离子、中性和阴离子四苯基卟啉衍生物在蓝光照耀下在浮游悬浮液中失活革兰氏阴性和革兰氏阳性细菌的能力。研究了一组亲脂性不同的光增敏剂的光谱、物理化学、氧化还原性质以及产生活性氧物种(ROS)的能力。进行了理论计算以解释评估化合物中分子电荷的分布。此外,还测定了光增敏剂的 logP 分配系数、细胞摄取率和对细菌的光毒性。还研究了特定微生物外排泵抑制剂盐酸维拉帕米在 PDI 中的作用。结果表明,与低光剂量(1-10 J/cm)相比, 对 PDI 的抗性更高(3-5 对数)。相反,照射时间的延长(高达 100 J/cm)显著提高了病原体的失活效率(高达 7 对数),并揭示了光增敏剂光稳定性的重要性。在加入碘化钾(额外杀死 3 对数以上)后,PDI 会增强。维拉帕米由于外排泵抑制作用增加了光增敏剂的摄取(尤其是 )。这种效应表明 PDI 是由 ROS、静电电荷相互作用和多药耐药(MDR)系统调节的光增敏剂(PS)的外排介导的。因此,MDR 抑制与 PDI 相结合为治疗更耐药的细菌提供了机会。